Ampio Pharmaceuticals
AMPE
#10582
Rank
A$0.42 M
Marketcap
A$0.37
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Ampio Pharmaceuticals (AMPE)

Earnings in 2023 (TTM): -A$12.93 Million

According to Ampio Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2022 earnings that were of -A$23.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ampio Pharmaceuticals from 2007 to 2023

Annual earnings

Year Earnings Change
2023 -A$12.4 Million-47.14%
2022 -A$23.46 Million-4.36%
2021 -A$24.52 Million7.42%
2020 -A$22.83 Million16.62%
2019 -A$19.58 Million-140.1%
2018 A$48.8 M-165.49%
2017 -A$74.52 Million170.77%
2016 -A$27.53 Million-30.16%
2015 -A$39.41 Million-29.73%
2014 -A$56.08 Million59.2%
2013 -A$35.23 Million111.58%
2012 -A$16.65 Million-36.57%
2011 -A$26.25 Million127.2%
2010 -A$11.56 Million758.38%
2009 -A$1.35 Million3105.94%
2008 -A$0.05 Million0.79%
2007 -A$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.52 B-375,401.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.01 B-137,403.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.68 B-94,377.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.38 B-59,704.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
A$0.17 B-1,512.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-A$0.12 Billion 819.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$33.38 Million 169.24%๐Ÿ‡บ๐Ÿ‡ธ USA